Oxidation of 5-Hydroxymethylfurfural into 2,5-Diformylfuran on Alkali Doped Ru/C Catalysts. Electron Properties of Ruthenium Species as Descriptor of Catalytic Activity.

Selective aerobic oxidation of 5-hydroxymethylfurfural into 2,5-diformylfuran has been achieved on alkali doped Ru/C catalyst. Optimization of Ru metal nanoparticles, as well as the nature and amount of the alkali dopant have been performed. The results showed that doping the Ru/C catalyst with controlled amount of potassium increases the catalytic activity, 2.

Concordance between dual indirect methods for assessing fat percentage.

Unlabelled: In the last decades there is a growing interest in the evaluation of human body composition for being an important part of the integral assessment of individuals. Its use has been extended to different disciplines associated with health care (medicine, nutrition, physiotherapy), and to sports and population fields. Specifically, fat percentage can be related to innumerable diseases.

Noble-Metal-Free Carbon Encapsulated CoNi Alloy Catalyst for the Hydrogenation of 5-(Hydroxymethyl) Furfural to Tetrahydrofurandiol in Aqueous Media.

The selective hydrogenation of 5-(hydroxymethyl)furfural (HMF) into 2,5-bis-(hydroxymethyl)tetrahydrofuran (BHMTHF) in flow reactor using water as a green solvent, has been achieved on a non-noble metal catalyst based on monodispersed CoNi alloy nanoparticles covered by a thin carbon layer. The alloyed catalyst containing CoNi (molar ratio 1 : 1) was prepared in a one-step synthesis following a hydrothermal method. Total conversion of HMF with 91 % selectivity to BHMTHF was achieved.

Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings.

Despite advancements in the early-stage detection and expansion of treatments for prostate cancer (PCa), patient mortality rates remain high in patients with aggressive disease and the overtreatment of indolent disease remains a major issue. Prostate-specific antigen (PSA), a standard PCa blood biomarker, is limited in its ability to differentiate disease subtypes resulting in the overtreatment of non-aggressive indolent disease. Here we assess engorged cancer-associated macrophage-like cells (CAMLs), a ≥50 µm, cancer-specific, polynucleated circulating cell type found in the blood of patients with PCa as a potential companion biomarker to PSA for patient risk stratification.

Decoding protein methylation function with thermal stability analysis.

Protein methylation is an important modification beyond epigenetics. However, systems analyses of protein methylation lag behind compared to other modifications. Recently, thermal stability analyses have been developed which provide a proxy of a protein functional status.